Search Results - "Wärnberg, F"

Risk of death from breast cancer after treatment for ductal carcinoma in situ by Wadsten, C., Garmo, H., Fredriksson, I., Sund, M., Wärnberg, F.

“…Background Studies to date have failed to demonstrate any survival benefit from preventing local recurrence after treatment for ductal breast carcinoma in situ…”
Get full text

Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer by Karakatsanis, A., Daskalakis, K., Stålberg, P., Olofsson, H., Andersson, Y., Eriksson, S., Bergkvist, L., Wärnberg, F.

“…Background Sentinel node biopsy (SNB) using superparamagnetic iron oxide (SPIO) nanoparticles is a novel method in breast cancer. Several studies have verified…”
Get full text

Meta‐analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer by Karakatsanis, A., Tasoulis, M. K., Wärnberg, F., Nilsson, G., MacNeill, F.

“…Background Neoadjuvant therapy (NAT) for operable breast cancer may facilitate more breast‐conserving surgery (BCS). It seems, however, that this benefit is…”
Get full text

Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ by Wadsten, C., Wennstig, A.-K., Garmo, H., Nilsson, Greger, Blomqvist, Carl, Holmberg, Lars, Fredriksson, Irma, Wärnberg, F., Sund, M.

“…Purpose The use of adjuvant radiotherapy (RT) in the management of ductal carcinoma in situ (DCIS) is increasing. Left-sided breast irradiation may involve…”
Get full text

Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study) by Karakatsanis, A., Hersi, A.‐F., Pistiolis, L., Olofsson Bagge, R., Lykoudis, P. M., Eriksson, S., Wärnberg, F., Nagy, G., Mohammed, I., Sundqvist, M., Bergkvist, L., Kwong, A., Olofsson, H., Stålberg, P.

“…Background One‐fifth of patients with a preoperative diagnosis of ductal carcinoma in situ (DCIS) have invasive breast cancer (IBC) on definitive histology…”
Get full text

Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap by Svee, A., Mani, M., Sandquist, K., Audolfsson, T., Folkvaljon, Y., Isern, A. E., Ringberg, A., Manjer, J., Falk‐Delgado, A., Wärnberg, F.

“…Background Women who undergo autologous breast reconstruction have been reported to have an increased risk of breast cancer recurrence compared with those who…”
Get full text

P221 Using an ultra-low dose of superparamagnetic iron oxide for sentinel lymph node detection in breast cancer patients - the MAGSNOW feasibility study by Mirzaei, N., Wärnberg, F., Zaar, P., Leonhardt, H., Bagge, R. Olofsson

Get full text

Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events by Karlsson, E, Sandelin, K, Appelgren, J, Zhou, W, Jirström, K, Bergh, J, Wärnberg, F

“…Abstract Background Emerging data propose biomarker alteration due to clonal selection between the primary invasive breast cancer and corresponding metastases…”
Get full text

High experienced continuity in breast cancer care is associated with high health related quality of life and compatible with good medical quality and approved lead times by Plate, S, Emilsson, L, Söderberg, M, Brandberg, Y, Wärnberg, F

Get full text

Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles by Karakatsanis, A., Olofsson, H., Stålberg, P., Bergkvist, L., Abdsaleh, S., Wärnberg, F.

“…Purpose: Sentinel node is routinely localized with the intraoperative use of a radioactive tracer, involving challenging logistics. Super paramagnetic iron…”
Get full text

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness by WÄRNBERG, F, NORDGREN, H, BERGKVIST, L, HOLMBERG, L

“…Ductal breast carcinoma in situ (DCIS) is regarded as a precursor to invasive breast cancer. The progression from in situ to invasive cancer is however little…”
Get full text

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort by Niméus‐Malmström, E., Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R.‐M., Jirström, K., Wärnberg, F., Blomqvist, C., Fernö, M., Fjällskog, M.‐L.

“…A large proportion of women with lymph node negative breast cancer do not benefit from chemotherapy. Proliferation markers have been shown to recognize…”
Get full text

Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples by Bindra, A, Muradrasoli, S, Kisekka, R, Nordgren, H, Warnberg, F, Blomberg, J

“…1 Section of Virology, Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden 2 Department of Genetics and Pathology, Uppsala University,…”
Get full text

43. Super paramagnetic iron oxide nanoparticles for sentinel node detection in patients with breast cancer: Experience from seven centres in Sweden and Denmark by Karakatsanis, A, Christiansen, P.M, Fischer, L, Hedin, C, Pistioli, L, Sund, M, Rasmussen, N.R, Jørnsgård, H, Tegnelius, D, Eriksson, S, Daskalakis, K, Wärnberg, F, Bergkvist, L

Get full text

P311 How to avoid unnecessary sentinel node biopsy in patients with ductal cancer in situ by Karakatsanis, A, Oloffson, H, Bergkvist, L.Å, Abdsaleh, S, Sund, M, Wärnberg, F

Get full text

Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast by Wärnberg, F, Amini, R-M, Goldman, M, Jirström, K

“…Aims:  Tissue microarray (TMA) is an efficient technique for analysis of molecular markers. Prospectively collected samples have been reported to give…”
Get full text

463: A molecular study of breast cancer progression stages from normal breast tissue to invasive cancer by Bergholtz, H, Lesurf, R, Myhre, S, Haakensen, V.D, Børresen-Dale, A.L, Bathen, T, Wärnberg, F, Kristensen, V.N, Helland, A, Sørlie, T

Get full text

Risk of subsequent invasive breast cancer after breast carcinoma in situ by Wärnberg, F, Yuen, J, Holmberg, L

“…The standardised incidence rates for invasive breast cancer were estimated in a cohort of 3455 women with a primary lobular or ductal carcinoma in situ of the…”
Get full text

Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression by Abdsaleh, S, Wärnberg, F, Azavedo, E, Lindgren, P G, Amini, R-M

Get full text

PO39 Placental weight and mortality in premenopausal breast cancer by tumour characteristics by Hajiebrahimi, M, Bahmanyar, S, Lambe, M, Adolfsson, J, Wärnberg, F, Cnattingius, S

Get full text